TAG:
laboratory executive
Business Premises Underlying Lab Industry Dynamics
By Robert Michel | From the Volume VII No. 18 – December 25, 2000 Issue
This chapter addresses the characteristics of the laboratory industry which define the starting point for changes and ongoing evolution. The eight business premises listed in this White Paper describe unique situations which directly influence the ability of clinical laboratories to serve the medical…
Medical Arts Lab Opts To File For Chapter 11 Bankruptcy
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: Dissident shareholders and a crushing debt burden are the reason Medical Arts Laboratory decided to file for reorganization under Chapter 11 bankruptcy laws. Both factors are the legacy of an ill-fated attempt to create a national laboratory organization between 1994 and 1997…
ISO 9000 Growing Across Lab Divisions of Quest Diagnostics
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
CEO SUMMARY: Currently the American healthcare system is struggling to evolve away from its “cottage industry†roots and adopt modern corporate management methods. Within the clinical laboratory industry, Quest Diagnostics Incorporated has staked out the high ground. Its strategic obj…
“October 23, 2000 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VII No. 15 – October 23, 2000 Issue
Get ready for the stock market to begin creating multi-millionaires from today’s generation of commercial laboratory executives. Most laboratorians know that Roche sold $430.5 million of its stock holding in Laboratory Corporation of America stock only seven days a…
MCOs Asking For More Lab Test Information
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
CEO SUMMARY: During the past 12 months, managed care companies in Michigan have increased the quantity and quality of the laboratory test information they want from their laboratory providers. Once again, the marketplace is raising the bar for competitive laboratory services. In response,…
Medicare HMO Program Debates Funding Levels
By Robert Michel | From the Volume VII No. 13 – September 11, 2000 Issue
CEO SUMMARY: Medicare+Choice was to offer seniors insurance options that went beyond standard Medicare fee-for-service services.Through the 1990s, seniors enrolled in Medicare HMOs at phenomenal rates. A recent GAO report repeated claims that Medicare HMOs are over-funded, to the tune of …
HMO Decline Predicted As PPOs Gain Enrollment
By Robert Michel | From the Volume VII No. 12 – August 21, 2000 Issue
CEO SUMMARY: Managed care analyst Michael Casey believes HMO enrollment will peak, possibly in 2000. PPOs (preferred provider organizations) are gaining members at an increasing rate. Within California, the provider revolt over deficient reimbursement levels is escalating. Orange County 
Qualigen’s POL PSA Test Cleared for Sale by FDA
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Qualigen, Inc. gained FDA approval to sell its FastPackâ„¢ System for PSA testing in the United States. Qualigen is one more example of a technology company that expects to shift diagnostic testing out of core laboratories and closer to the patient. Initially Qualigen will se…
Dr. Bruce Friedman Identifies Market Dynamics Driving Evolution of Lab Information Services
By Robert Michel | From the Volume VII No. 11 – July 31, 2000 Issue
CEO SUMMARY: Probably no one is better positioned to identify the evolution of laboratory information services than Bruce Friedman, M.D., Professor of Pathology at the University of Michigan Medical School in Ann Arbor. For almost 20 years, he has hosted the pre-eminent meeting in laborat…
Beckman Coulter’s Strategy Reflects Consolidation Trends
CEO SUMMARY: Rapid changes to the clinical laboratory industry had equally profound impact upon the major diagnostic companies. At Beckman Coulter, Inc., market forces triggered a decade of acquisitions and internal consolidation.The company looks very different today than it did ten year…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized